BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

491 related articles for article (PubMed ID: 30674324)

  • 1. Circular RNA profiling and its potential for esophageal squamous cell cancer diagnosis and prognosis.
    Fan L; Cao Q; Liu J; Zhang J; Li B
    Mol Cancer; 2019 Jan; 18(1):16. PubMed ID: 30674324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel upregulated hsa_circ_0032746 regulates the oncogenesis of esophageal squamous cell carcinoma by regulating miR-4270/MCM3 axis.
    Shrestha SM; Fang X; Ye H; Ren L; Ji Q; Shi R
    Hum Genomics; 2024 Jan; 18(1):3. PubMed ID: 38200573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exosomal circRNAs in the plasma serve as novel biomarkers for IPF diagnosis and progression prediction.
    Gan W; Song W; Gao Y; Zheng X; Wang F; Zhang Z; Zen K; Liang H; Yan X
    J Transl Med; 2024 Mar; 22(1):264. PubMed ID: 38462601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circular RNA hsa-circ-0006203 - hsa-circ-0004872 as novel detecting biomarkers in oral cancer.
    Ghaffari Monfared H; Taheri Sangsari G; Jamshidian F
    Klin Onkol; 2023; 36(4):378-381. PubMed ID: 37877530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hsa_circ_0001707 regulates endothelial-mesenchymal transition in esophageal squamous cell carcinoma via miR-203a-3p/Snail2 pathway.
    Gao H; Sun M; Gao Z; Song J; Tang D; Liu R
    Environ Toxicol; 2024 Mar; 39(3):1210-1220. PubMed ID: 37921085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Circular RNA hsa_circ_0006834 is a potential prognostic biomarker for hepatocellular carcinoma].
    Zhang L; Zhao C; Xu Y; Chen Y; Cai Z; Lin H; Cai Q
    Nan Fang Yi Ke Da Xue Xue Bao; 2023 Nov; 43(11):1850-1856. PubMed ID: 38081601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biological and clinical implications of metastasis-associated circular RNAs in oesophageal squamous cell carcinoma.
    Fang X; Shrestha SM; Ren LH; Shi RH
    FEBS Open Bio; 2021 Nov; 11(11):2870-2887. PubMed ID: 34510785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The diagnostic potential of two exosome-derived circRNAs for papillary thyroid cancer.
    Dai L; Hu W; Jiang H; Wang Y; Le Q; Wu X; Meng X
    Int J Clin Oncol; 2023 Nov; 28(11):1461-1474. PubMed ID: 37568034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased expression of hsa_circ_001988 in colorectal cancer and its clinical significances.
    Wang X; Zhang Y; Huang L; Zhang J; Pan F; Li B; Yan Y; Jia B; Liu H; Li S; Zheng W
    Int J Clin Exp Pathol; 2015; 8(12):16020-5. PubMed ID: 26884878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brain-Derived Exosomal CircRNAs in Plasma Serve as Diagnostic Biomarkers for Acute Ischemic Stroke.
    Jiang X; Zhang R; Lu G; Zhou Y; Li J; Jiang X; Gu S; Liang H; Wang J
    J Neuroimmune Pharmacol; 2024 Apr; 19(1):15. PubMed ID: 38647743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of CCND1 amplification/overexpression in smoking patients with esophageal squamous cell carcinoma.
    Jiang D; Song Q; Zhang F; Xu C; Li X; Zeng H; Su J; Huang J; Xu Y; Lu S; Hou Y
    Cancer Genet; 2023 Nov; 278-279():1-8. PubMed ID: 37556965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigation of
    Mozooni Z; Golestani N; Sadeghi H
    Gastroenterol Hepatol Bed Bench; 2024; 17(1):37-44. PubMed ID: 38737931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prognostic value of circRNAs for gastric cancer: A systematic review and meta-analysis.
    Chen H; Liang C; Wang X; Liu Y; Yang Z; Shen M; Han C; Ren C
    Cancer Med; 2020 Dec; 9(23):9096-9106. PubMed ID: 33108710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular analysis of Chinese oesophageal squamous cell carcinoma identifies novel subtypes associated with distinct clinical outcomes.
    Liu M; An H; Zhang Y; Sun W; Cheng S; Wang R; Wang X; Feng L
    EBioMedicine; 2020 Jul; 57():102831. PubMed ID: 32580137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantification of plasma exosome is a potential prognostic marker for esophageal squamous cell carcinoma.
    Matsumoto Y; Kano M; Akutsu Y; Hanari N; Hoshino I; Murakami K; Usui A; Suito H; Takahashi M; Otsuka R; Xin H; Komatsu A; Iida K; Matsubara H
    Oncol Rep; 2016 Nov; 36(5):2535-2543. PubMed ID: 27599779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progress in the blood-based diagnosis of oesophageal squamous cell carcinoma (ESCC) using microRNAs: Comment on Komatsu et al. (BJC (2011) 105, 104-111).
    Lawrie CH
    Br J Cancer; 2023 Feb; 128(3):446-447. PubMed ID: 36307646
    [No Abstract]   [Full Text] [Related]  

  • 17. Feasibility evaluation of hsa_circ_0005480 as an auxiliary diagnostic and prognostic indicator for gastric cancer.
    Yu J; Lu K; Huang H; Wang J; Yang Q
    Biomark Med; 2023 Jul; 17(13):585-595. PubMed ID: 37902590
    [No Abstract]   [Full Text] [Related]  

  • 18. A SARS-CoV-2 related signature that explores the tumor microenvironment and predicts immunotherapy response in esophageal squamous cell cancer.
    Ren Q; Zhang P; Zhang S; Chen W; Chi H; Wang W; Zhang W; Lin H; Yu Y
    Aging (Albany NY); 2023 Oct; 15(19):10501-10523. PubMed ID: 37812215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early development of esophageal squamous cell cancer: Stem cells, cellular origins and early clone evolution.
    Liao G; Tang J; Bai J
    Cancer Lett; 2023 Feb; 555():216047. PubMed ID: 36587837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A pathway-based computational framework for identification of a new modal of multi-omics biomarkers and its application in esophageal cancer.
    Zhou Q; Ye W; Yu X; Bao YJ
    Comput Methods Programs Biomed; 2024 Apr; 247():108077. PubMed ID: 38382307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.